Table 2.
Histology according to referral cytology
| Histology | ||||||
|---|---|---|---|---|---|---|
| Normal | CIN1 | CIN2+ | ||||
| n | % | n | % | n | % | |
| Referral cytology | ||||||
| Persistent HPV infection (n = 4) | 3 | 75 | 0 | 0 | 1 | 25 |
| ASCUS (n = 13) | 5 | 39 | 6 | 46 | 2 | 15 |
| LSIL (n = 11) | 6 | 55 | 1 | 9 | 4 | 36 |
| AGUS (n = 37) | 24 | 65 | 6 | 16 | 7 | 19 |
| ASC‐H (n = 129) | 35 | 27 | 18 | 14 | 76 | 59 |
| HSIL (n = 98) | 10 | 10 | 6 | 6 | 82 | 84 |
| ACIS (n = 2) | 0 | 0 | 0 | 0 | 2 | 100 |
| Othera (n = 3) | 1 | 33 | 1 | 33 | 1 | 33 |
| Total (n = 297) | 84 | 28 | 38 | 13 | 175 | 59 |
CIN, cervical intraepithelial neoplasia; ASCUS, atypical squamous cells of uncertain significance; LSIL, low‐grade squamous intraepithelial lesion; AGUS, atypical glandular cells of uncertain significance; ASC‐H, atypical squamous cells cannot exclude high‐grade squamous intraepithelial lesion; HSIL, high‐grade squamous intraepithelial lesion; ACIS, adenocarcinoma in situ.
a
Includes one women with LSIL where HSIL cannot be excluded, one adenocarcinoma and one where adenocarcinoma cannot be excluded.